EUVIMEDEUVIMED entdecken
Crossref

Formulation and Evaluation of Transdermal Patch of Acetyl Salicylic Acid

B. V. Nagarjuna Yadav B. V. Nagarjuna Yadav, Shubhangi N Pillewan Shubhangi N Pillewan, KetakeeNichat KetakeeNichat, Ankit P Papalkar Ankit P Papalkar, Harsh N Dala Harsh N Dala, Anisha I Vidhani Anisha I Vidhani, Shreyas P Tiwaskar Shreyas P Tiwaskar, Shreya A Dewang Shreya A Dewang

International Journal of Pharmaceutical Science Invention · 2025

DOI: 10.35629/6718-14020108 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Pharmaceutical Science Invention, 2025. Verfasst von B. V. Nagarjuna Yadav B. V. Nagarjuna Yadav und 7 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The objective of this research aimed to develop and evaluate a novel transdermal patch formulation of Acetylsalicylic acid (ASA) as an alternative to conventional oral dosage. Oral use of ASA is frequently associated with low absorption and severe gastrointestinal symptoms due to first-pass metabolism and direct mucosal irritation. To overcome these limitations, we developed a patch that incorporates ASA into a polymeric matrix, enabling controlled and extended skin release of the medication. In addition to carefully selected polymers and plasticizers that were specifically designed to maintain medication stability and ensure product uniformity, solvent evaporation methods were employed throughout the formulation process. Important physicochemical characteristics of the transdermal patches, including weight fluctuation, thickness, folding durability, moisture absorption, and drug content homogeneity, were thoroughly assessed. Permeation tests and in vitro dissolution investigations were also carried out to evaluate the medication delivery rate and release profile. According to our findings, the patches delivered a prolonged release of ASA with remarkable mechanical strength and uniformity, offering great promise for better therapeutic benefits and increased patient compliance. In addition to proving that transdermal ASA delivery is feasible, this study establishes the foundation for future investigations into other administration routes that lessen systemic adverse effects and enhance overall safety.

Zitieren

APA

Yadav, B. V. N. Y. B. V. N., Pillewan, S. N. P. S. N., KetakeeNichat, K., Papalkar, A. P. P. A. P., Dala, H. N. D. H. N., Vidhani, A. I. V. A. I., Tiwaskar, S. P. T. S. P., & Dewang, S. A. D. S. A. (2025). Formulation and Evaluation of Transdermal Patch of Acetyl Salicylic Acid. International Journal of Pharmaceutical Science Invention. https://doi.org/10.35629/6718-14020108

Vancouver

Yadav BVNYBVN, Pillewan SNPSN, KetakeeNichat K, Papalkar APPAP, Dala HNDHN, Vidhani AIVAI, et al. Formulation and Evaluation of Transdermal Patch of Acetyl Salicylic Acid. International Journal of Pharmaceutical Science Invention. 2025. doi:10.35629/6718-14020108

BibTeX
@article{Yadav2025,
  author = {Yadav, B. V. Nagarjuna Yadav B. V. Nagarjuna and Pillewan, Shubhangi N Pillewan Shubhangi N and KetakeeNichat, KetakeeNichat and Papalkar, Ankit P Papalkar Ankit P and Dala, Harsh N Dala Harsh N and Vidhani, Anisha I Vidhani Anisha I and Tiwaskar, Shreyas P Tiwaskar Shreyas P and Dewang, Shreya A Dewang Shreya A},
  title = {Formulation and Evaluation of Transdermal Patch of Acetyl Salicylic Acid},
  journal = {International Journal of Pharmaceutical Science Invention},
  year = {2025},
  doi = {10.35629/6718-14020108}
}
Kostenlos starten →